U.S. Mortgage Finance Stock News

NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

A Look At Collegium Pharmaceutical (COLL) Valuation As Earnings Jump And AZSTARYS Acquisition Is Proposed

Collegium Pharmaceutical (COLL) is back in focus after reporting first quarter 2026 earnings that showed a sharp jump in profitability and progress across its ADHD and pain portfolios, alongside a proposed AZSTARYS acquisition. See our latest analysis for Collegium Pharmaceutical. Despite the strong first quarter earnings and the proposed AZSTARYS deal, Collegium Pharmaceutical’s share price performance has been mixed. The 7 day share price return was 9.31%, but the 90 day share price return...
NYSE:BLD
NYSE:BLDConsumer Durables

Did TopBuild’s (BLD) Profit Squeeze Amid Rising Sales Just Shift Its Investment Narrative?

TopBuild Corp. has already reported first-quarter 2026 results, with sales rising to US$1,445.86 million from US$1,233.28 million a year earlier, while net income decreased to US$104.81 million from US$123.39 million. The combination of higher revenue but lower net income and earnings per share highlights pressure on TopBuild’s profitability despite ongoing top-line growth. Next, we’ll examine how this mix of revenue growth and thinner earnings margins may influence TopBuild’s investment...